1,600 Shares in CVS Health Co. (NYSE:CVS) Acquired by nVerses Capital LLC

nVerses Capital LLC acquired a new stake in CVS Health Co. (NYSE:CVS) during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,600 shares of the pharmacy operator’s stock, valued at approximately $101,000.

A number of other large investors also recently modified their holdings of CVS. Pzena Investment Management LLC increased its position in shares of CVS Health by 132.9% in the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after purchasing an additional 7,382,931 shares during the last quarter. Capital International Investors increased its position in shares of CVS Health by 12.5% in the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock valued at $3,024,334,000 after purchasing an additional 4,226,225 shares during the last quarter. Capital World Investors increased its position in shares of CVS Health by 8.0% in the 1st quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after purchasing an additional 3,232,172 shares during the last quarter. State of Michigan Retirement System increased its position in shares of CVS Health by 402.5% in the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock valued at $118,455,000 after purchasing an additional 1,606,500 shares during the last quarter. Finally, Swedbank AB purchased a new stake in shares of CVS Health in the 1st quarter valued at approximately $110,816,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 5.2 %

CVS stock opened at $60.34 on Monday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a fifty day moving average of $59.80 and a 200-day moving average of $60.43. The stock has a market capitalization of $75.75 billion, a PE ratio of 10.60, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter last year, the business earned $2.21 earnings per share. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, analysts expect that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.41%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 46.75%.

Analyst Ratings Changes

A number of research analysts recently commented on CVS shares. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $63.00 to $82.00 in a research report on Thursday, October 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Truist Financial increased their target price on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. Finally, TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and increased their target price for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.